SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-008920
Filing Date
2021-04-15
Accepted
2021-04-15 17:01:02
Documents
79
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2343253
2 ex3-5.htm EX-3.5 1027
3 ex23-1.htm EX-23.1 3279
4 ex31-1.htm EX-31.1 22480
5 ex31-2.htm EX-31.2 20253
6 ex32-1.htm EX-32.1 6264
7 ex32-2.htm EX-32.2 6022
8 ex3-5_001.jpg GRAPHIC 151220
  Complete submission text file 0001493152-21-008920.txt   7956051

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE otlc-20201231.xml EX-101.INS 1059641
10 XBRL SCHEMA FILE otlc-20201231.xsd EX-101.SCH 65747
11 XBRL CALCULATION FILE otlc-20201231_cal.xml EX-101.CAL 68833
12 XBRL DEFINITION FILE otlc-20201231_def.xml EX-101.DEF 410053
13 XBRL LABEL FILE otlc-20201231_lab.xml EX-101.LAB 478891
14 XBRL PRESENTATION FILE otlc-20201231_pre.xml EX-101.PRE 471182
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 21829181
SIC: 2834 Pharmaceutical Preparations